Viking Systems (VKSYE) 8-K Regulation FD Disclosure

Exhibit 99.1

Excellence in Surgical Visualization

Corporate Presentation

1

July 2010 w

Excellence in Surgical Visualization

Safe Harbor

This presentation contains forward-looking statements. These forward-
looking statements are estimates reflecting the best judgment of our
management and involve a number of risks and uncertainties that could
cause actual results to differ materially from those suggested by the forward
-looking statements. These forward-looking statements should, therefore,
be considered in light of various important factors as described in our
annual report on Form 10-K under the heading "Risk Factors" as updated
from time to time by our quarterly reports on Form 10-Q and our other filings
with the Securities and Exchange Commission. Statements concerning
forecasts, revenue growth, procedure growth, future financial results, and
statements using words such as "estimate", "project", "plan", "intend",
"expect", "anticipate", "believe" and similar expressions are intended to
identify forward-looking statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the
date of this presentation. We undertake no obligation to publicly update or
release any revisions to these forward-looking statements to reflect events
or circumstances after the date of this presentation or to reflect the
occurrence of unanticipated events.

This presentation should not be construed as an offer to buy or sell securities

2

Excellence in Surgical Visualization

The Company

•Viking Systems (OTCBB: VKNG) is a leading worldwide
developer, manufacturer and marketer of 2D and 3D
visualization solutions for complex minimally invasive surgery.

•The Company actively markets and sells the only stand alone,
cost effective 3D vision system for use in minimally invasive
surgery.

•The Company believes performing complex minimally invasive
procedures with a 3D vision system has the potential not only
to improve the quality of care but also to reduce procedure
time and therefore cost of procedures.

3

Excellence in Surgical Visualization

Management Team

•Bill Bopp: Chairman

–ALARIS: Sr. VP & CFO

–C.R. Bard: EVP & CFO

–Harvard University, AB & MBA

•Jed Kennedy: President & CEO

–Vista Medical Technologies: EVP & COO

–Smith & Nephew: Group Director, Product
Development

–Boston University, BS

•Rob Mathews: EVP & CFO

–Cardinal Health’s Clinical Technologies and
Services : SVP & CFO

–ALARIS: Vice President of Finance & CAO

–Price Waterhouse

–San Diego State University, BS

•Yuri Kazakevich: Vice President, R&D

–Smith & Nephew: R&D Manager,
Visualization

–Science and Technology Corporation of the
Academy of Sciences of the USSR: Principal
Engineer

–Institute of Fine Mechanics and Optics,
Leningrad, USSR, BS & MS

•Rob Tierney: VP, US Sales & Clinical Dev.

–Precision Optics: Director of Sales

–Smith & Nephew: Vice President of Sales

–Tierney Associates: Principal

–Western Michigan University, BS

–University of Florida, BS (Physicians Assistant-
Certified)

•Fred Calnan: VP, International & OEM Sales

–Trivirix International: Director of Business
Development

–Plexus: Account Executive Medical Sector

–Babson College, MBA

–University of Limerick, BS

•Terry Donovan: Vice President, Operations

–Donovan Consulting Company: Principal

–Smith & Nephew; Vice President of Manufacturing

–Schott Fiber Optics Corp.: Manufacturing
Manager

–Northeastern University, MBA

–Merrimack College, BS

4

Excellence in Surgical Visualization

Historical Background

•January 2008

ØRestructured business model to reduce expenses

ØNew management and Board of Directors

ØSimplified capital structure with refinancing

• Improved P&L and cash flow in 2009

5

Excellence in Surgical Visualization

Selected Financial Data

•SymbolVKNG.OB

•2009 Sales$7.2 million

•2009 Op. Loss*$0.5 million

•Shares O/S53.3 million

•Recent Price$0.21 - $0.27

•Market Capapprox. $12 million

•52 week range$0.01 - $1.10

*excluding noncash charges

6

Excellence in Surgical Visualization

Opportunity

•Major new product cycle unfolding around 3D vision
systems

•Viking is currently the only known supplier of stand
alone, cost effective 3D vision systems

•5% market conversion represents $100,000,000 sales

•Potential to roll up with disposable instruments for “robot
lite” to address newly created multi-billion dollar market

7

Excellence in Surgical Visualization

Intellectual Property Portfolio

•Fourteen issued US patents

•Four Licensed US patents

•Three Provisional Patents filed

•Four Disclosures in progress

•Substantial 3D vision system “know how”

8

Excellence in Surgical Visualization

•Restores the surgeon’s natural 3D vision and depth
perception

•Provides depth cues and precise spatial orientation

•Shown to enhance dissection, grasping skills, suturing,
stapling and overall surgical efficiency*

•Requires no additional certification or training for those
surgeons certified to perform laparoscopic procedures

•Enhances task performance leading to lower procedure
times and costs*

*data on file

Benefits of Viking

9

Excellence in Surgical Visualization

Independent Study
Demonstrating Benefits of 3D3D vision enhances task performance independent of the surgical methodO.J. Wagner (1,2) , M. Hagen (2) , M. Talamini (2) , S. Horgan (2) , A. Kurmann (1) ,
1D. Candinas (1) , 1S.A. Vorburger (1)
1) Department of Visceral and Transplantation Surgery, Inselspital, University Hospital Bern and University of Bern, Switzerland
2) Center for the Future of Surgery, Department of Surgery, University of California - San Diego,USA

•Background

Despite obvious advantages of minimally invasive surgery, laparoscopy lacks of natural
stereoscopic depth perception and spatial orientation. Therefore, these 2 parameters appear to
represent mayor downsides of minimal-invasive surgery. Still, the importance and overall negative
effect of this lack of natural stereoscopic depth perception and spatial orientation has not been
clearly demonstrated. The aim of this study was to evaluate if three-dimensional (3D) visualization
improves surgical skills and task performance when compared to two-dimensional (2D) vision.

•Conclusion

All tasks were completed faster with 3D vision compared to 2D vision. The more complex a task,
the more 3D vision sped up task completion compared to 2D vision, independent of the surgical
modality. A major factor for improved task performance of robotic-assisted surgery (3D) compared
to conventional (2D) laparoscopy is the improved vision.

(Presented at the European Association of Endoscopic Surgeons, June 2009. ,manuscript is currently underreview by “Endoscopy.”)

10

Excellence in Surgical Visualization

12

Excellence in Surgical Visualization

•Robotic surgery brought 3D visualization to the OR

•3DHD enables complex minimally invasive procedures

•Emergence of 3D flat panel display technology

13

Excellence in Surgical Visualization

Notable Quotes

•Dr. Gerald Andriole, Chief of Urological Surgery, Washington U. in St. Louis, MO:

"Viking’s Next Generation 3DHD system represents a huge improvement over 2D HD visualization in laparoscopic
surgery. Having a 3D image gives the surgeon superb control while manipulating needles for intracorporal sewing,
making knot tying simple."

•Dr. Sam Bhayani, Co-Director of Robotic Surgery, Div. of Urological Surgery, Washington U. St. Louis, MO:

“This 3D image is as good as any I have ever seen in my robotic procedures.I feel more in control and extraordinarily
comfortable. It allows me to regain tactile feedback without sacrificing superior visualization.“

•Dr. Eric J. DeMaria, Chief of Surgery at Durham Regional Hospital:

“Using 3D cameras in the OR has changed my sense of depth and space while performing minimally invasive surgery.
In our recent tests, 3D technology has helped provide a truer visual experience - similar to that of natural sight, even
when performing laparoscopic surgical tasks deep within the abdominal cavity.”

•Dr. Colleen Feltmate, Director Minimally Invasive GYN-Oncologic Surgery, Brigham & Women’s Hospital,
Boston, MA:

“I was quite impressed with the Viking 3DHD system.  I really am looking forward to trialing it out in surgery to see how
much faster and/or precise it makes me.”

•Dr. Alistair Phillips, Attending Cardio Vascular Surgeon at The Heart Center at Nationwide Children’s Hospital
and assistant professor of Surgery at The Ohio State University College of Medicine, Columbus, OH :

“The Viking 3D system has become a very important part of our practice and will have an ever increasing role, especially
with the improvements Viking has made with the new 3DHD System.”

14

Excellence in Surgical Visualization

Minimally Invasive Camera
Systems Market Data

• US market 2DHD Systems estimated at $800 million for 2011

• Global market estimated at approximately $ 2.0 billion*

• In 2005 only 12% of systems placed were HD; in 2008 the number was closer to 65%

• ASP for a standard definition camera system is $25,000 - $40,000 (end user)

• ASP for a high definition camera system is $40,000 - $65,000 (end user)

• Number of MIS procedures performed is growing as technology enables more
procedures to convert from open.High quality vision is essential to this conversion.

*Includes various combinations of cameras, lightsources, monitors, recorders, carts and displays. (Excludes $1.0 Billion in endoscopes)

15

Excellence in Surgical Visualization

VIKING is uniquely positioned in the gap between conventional 2D HD
systems and the 3D HD visualization systems available only as part of high
cost robotic systems, this represents a two billion dollar market
opportunity……..

Market Opportunity for

--------------------MinimallyInvasive (MIS) Vision Market----------------------

16

Stryker

Storz

Richard Wolf

Linvatec

Intuitive

Viking Systems

Market Opportunity

25, 000 to 30,000/yr

1 CHIP SD

3 CHIP SD

Surgical

Robotics

~350/yr

Laparoscopic

Urology

GYN

General Surgery

Thoracic

Convert

”

2D HD

Excellence in Surgical Visualization

•Building Surgeon & Brand Awareness

17

Excellence in Surgical Visualization

American College of Surgeons
96thClinical Congress

•October 3-7, 2010

•9,000 domestic and international surgeons

•20’ X 40’ booth on main aisle

•Co-marketing plans with Sony

18

Excellence in Surgical Visualization

•Primary Goal

–Develop regional distributors that will allow continued growth through clinical experience and
positive referrals

•Distributor Focus

–Surgical vision system experience

–Complementary product offerings

–Operating room as primary call point

•Primary launch targets

–United States

–Italy

–France

–Spain

–Central Europe (Austria/Czech Republic/Poland)

–S. Korea

•Second phase

–Germany/UK/China/Japan/Switzerland/Latin America/Turkey

•Clinical Focus

–General Surgery/GYN/Urology/Thoracic

19

Excellence in Surgical Visualization

20

•1,000 systems= sales of approx. $70-$90 MM

•2,000 systems= sales of approx. $140-$180 MM

•3,000 systems= sales of approx. $210-$270 MM

Excellence in Surgical Visualization

Beyond Stand Alone

3D for robotic surgical systems

–We believe robotic surgical systems require 3D
visualization. Viking is well positioned to provide 3D
visualization solutions to robotic surgical system
manufacturers

•Enabling advanced technologies for laparoscopic
surgery

21

Excellence in Surgical Visualization

Automated

Scope

Positioner*

Strategic Opportunity

•Completes Solution

•Establishes Market Domain

•Expands Clinical Relevancy

•Drives ‘Price-to-Value’

Example advanced technology
combination for laparoscopic
surgery

22

* Non Viking technology potentially

available for combination.

Excellence in Surgical Visualization

Surgical Robotic System

Capital Equipment$1.4MM

Annual service agreement$142K

Per Procedure consumable$1,900

2009 procedure total205,000

Advanced Laparoscopic System with

Capital Equipment$<250K

Annual service agreement$0

Per Procedure consumable$500-1500

2009 MIS procedures3,000,000+

Cost Comparison

23

Excellence in Surgical Visualization

OEM Business

“A Valued Partner in the Growth of Medical Technology”

üFDA registered

üISO 13485 certified

üCredible Customer List

•Boston Scientific

•Medtronic

•B. Braun

•Richard Wolf

üSkilled Work Force

üClean Room Facilities

üElectro- Mechanical Assembly

üOptical Assembly

üMedical Device Design Expertise

•Analog & Digital Electronics

•Firmware

•Mechanical

•Optical

üDesign Tools

•Solid Works

•AutoCad

•ORCAD

•ZEMAX

üRegulatory Affairs Expertise

•US & ROW

Viking Systems operates a Medical Technology - OEM business,
manufacturing andassembling 3-D and 2-D cameras and components
made for several top-level and widely recognized medical instrument
companies worldwide. Viking sells these components direct to contracted
clients, as well as throughstrategic partners.

Medical Technology Capabilities:

24

Excellence in Surgical Visualization

Summary

•Unique product to address $2 billion surgical vision market

•Enabling technology of multi-billion surgical robotic market which
can provide a platform for growth

•Experienced management team

•Strong intellectual property portfolio & proprietary “know how”

•Publicly traded equity

•Operates in Health Care Market Segment

25

Excellence in Surgical Visualization

Thank You

26